Inventor · disambiguated record
Nadiya Sydorenko
Also filed as: SYDORENKO NADIYA
14 granted patents·9 pending applications·27 citations·filing 2009–2023
87Inventor score
Top patents by PatentIndex Score
23 records- 0191US10874672B2Methods for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2016·Granted Dec 29, 2020·13 cites·28 claims
- 0281US10881658B2Methods for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Jan 5, 2021·2 cites·12 claims
- 0381US10370371B2Substituted pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Aug 6, 2019·3 cites·7 claims
- 0480US10428050B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Oct 1, 2019·4 cites·8 claims
- 0578US11180483B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·1 cites·16 claims
- 0678US2023201200A1Methods for Treating Huntington’s DiseasePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0772US2023331725A1Compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0871US11638706B2Methods for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2020·Granted May 2, 2023·0 cites·8 claims
- 0971US10584115B2Substituted pyridine and pyrazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2020·1 cites·17 claims
- 1070US2022064150A1Substituted reverse pyrimidine bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1169US8680113B2BMI-1 protein expression modulatorsMOON YOUNG-CHOON·Filed 2009·Granted Mar 25, 2014·3 cites·16 claims
- 1262US12103926B2Compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2024·0 cites·4 claims
- 1362US2024132509A1Heterocyclic and heteroaryl compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1459US11858941B2Heterocyclic and heteroaryl compounds for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Jan 2, 2024·0 cites·16 claims
- 1559US2024336613A1Heteroaryl compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1658US11780839B2Compounds for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Oct 10, 2023·0 cites·12 claims
- 1758US2025353855A1Heterocyclic and heteroaryl compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1857US2025179078A1Inhibitors of nlrp3PTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1955US2024262806A1Inhibitors of nlrp3PTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2049US2023234942A1Compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2145US9975878B2Substituted triazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted May 22, 2018·0 cites·19 claims
- 2244US12139499B2Heteroaryl compounds for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2024·0 cites·9 claims
- 2341US11382918B2Methods for treating Huntington's DiseasePTC THERAPEUTICS INC·Filed 2018·Granted Jul 12, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Nadiya Sydorenko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →